Medacta Group SA

Medacta Group SA maintains a debt-to-equity ratio of 0.57, indicating a moderate reliance on debt financing, and a current ratio of 2.08, suggesting adequate short-term liquidity to cover its obligations. The company's free cash flow of 12.1 million EUR is significantly lower than its operating cash flow of 152.7 million EUR, primarily due to capital expenditures of 143.1 million EUR. This capital outlay may reflect ongoing investments in production or expansion. The company's profitability is reflected in a return on equity of 20.91% and a return on assets of 10.4%, both of which are strong indicators of efficient use of equity and assets to generate profit. These metrics suggest that Medacta Group SA is performing well in terms of profitability relative to its capital base. Medacta Group SA's revenue is concentrated in the medical equipment and supplies segment, with no disclosed geographic diversification in the provided data. The company's primary business is centered around orthopedic and spine surgical products, which are its core offerings. There is no indication of significant diversification into other product lines or geographic regions. The company's growth trajectory is not explicitly detailed in the provided data, but the capital expenditure of 143.1 million EUR suggests a strategic investment in future growth. Analysts have provided a mean price target of 169.25 EUR and a median price target of 170.50 EUR, indicating a generally positive outlook. However, the absence of strong-buy recommendations and the presence of four buy and one hold recommendation suggest a cautious optimism among analysts. The risk assessment for Medacta Group SA indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could pose a challenge in maintaining liquidity. The low dilution risk is supported by the fact that the number of shares outstanding has not changed between basic and diluted shares, indicating no imminent threat of share dilution. Recent events and filings have not been detailed in the provided data, but the company's financial snapshot and analyst estimates suggest a stable and growing business. The company's capital structure and liquidity position are being closely monitored by analysts, as reflected in the price targets and recommendations.